CytoDyn (CYDY) Return on Assets (QoQ) (2011 - 2026)

CytoDyn (CYDY) Return on Assets (QoQ) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 CytoDyn 258.01 Mn 258.01 Mn -

Historic Data

Download Data
DateValue
Feb 28, 2026 1.00
Nov 30, 2025 -2.00
Aug 31, 2025 -2.00
May 31, 2025 0.00
Feb 28, 2025 0.00
Nov 30, 2024 0.00
Aug 31, 2024 4.00
May 31, 2024 1.00
Feb 29, 2024 0.00
Nov 30, 2023 1.00
Aug 31, 2023 0.00
May 31, 2023 7.00
Feb 28, 2023 -4.00
Nov 30, 2022 -3.00
Aug 31, 2022 -3.00
May 31, 2022 -1.00
Feb 28, 2022 0.00
Nov 30, 2021 0.00
Aug 31, 2021 0.00
May 31, 2021 0.00